SEC Comment Letter 0000000000-23-008402 to INSPIRE VETERINARY PARTNERS, INC. (IVPR)
INSPIRE VETERINARY PARTNERS, INC.
Date: Aug. 4, 2023 · CIK: 0001939365 · Accession: 0000000000-23-008402
AI Filing Summary & Sentiment
File numbers found in text: 333-271198
Show Raw Text
United States securities and exchange commission logo
August 4, 2023
Kimball Carr
Chief Executive Officer
Inspire Veterinary Partners, Inc.
780 Lynnhaven Parkway
Suite 400
Virginia Beach, VA 23452
Re:Inspire Veterinary Partners, Inc.
Amendment No. 5 to Registration Statement on Form S-1
Filed August 2, 2023
File No. 333-271198
Dear Kimball Carr:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our July 31, 2023 letter.
Amendment No. 5 to Registration Statement on Form S-1
General
1.We note that your free writing prospectus, filed July 27, 2023, includes a 2023-24 forecast
of, among other things, target 2023 revenue and earnings. Please tell us how this
information is consistent with the requirements of Rule 433(c). We note that your
prospectus does not appear to contain 2023 projections and the basis for your revenue and
earnings projections is unclear absent compliance with Item 10(b) of Regulation S-K.
FirstName LastNameKimball Carr
Comapany NameInspire Veterinary Partners, Inc.
August 4, 2023 Page 2
FirstName LastName
Kimball Carr
Inspire Veterinary Partners, Inc.
August 4, 2023
Page 2
You may contact Nudrat Salik at 202-551-3692 or Terence O'Brien at 202-551-3355 if
you have questions regarding comments on the financial statements and related matters. Please
contact Conlon Danberg at 202-551-4466 or Katherine Bagley at 202-551-2545 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Joe Laxague, Esq.